MedPath

A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides

Phase 3
Completed
Conditions
Pneumonia, Pneumocystis Carinii
HIV Infections
Registration Number
NCT00001028
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

To compare the safety and efficacy of aerosolized pentamidine and dapsone in the prevention of Pneumocystis carinii pneumonia (PCP) in high-risk HIV-infected patients who are intolerant to trimethoprim and/or sulfonamides.

Both aerosolized pentamidine and dapsone have been shown to prevent PCP, but both drugs cause side effects. This study attempts to determine which drug is more efficacious as prophylaxis against PCP in patients who cannot tolerate trimethoprim/sulfamethoxazole.

Detailed Description

Both aerosolized pentamidine and dapsone have been shown to prevent PCP, but both drugs cause side effects. This study attempts to determine which drug is more efficacious as prophylaxis against PCP in patients who cannot tolerate trimethoprim/sulfamethoxazole.

Patients are evenly divided between two treatment arms to receive either aerosolized pentamidine every 4 weeks or dapsone orally three times weekly. Follow-up data is collected every 3 months, and patients are clinically evaluated every 6 months. Patients who develop PCP or a severe or persistent study drug toxicity may be switched to the alternative study drug at the clinician's discretion. Average duration of follow-up is 2 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (14)

Community Consortium of San Francisco

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco, California, United States

Denver CPCRA / Denver Public Hlth

๐Ÿ‡บ๐Ÿ‡ธ

Denver, Colorado, United States

Wilmington Hosp / Med Ctr of Delaware

๐Ÿ‡บ๐Ÿ‡ธ

Wilmington, Delaware, United States

Veterans Administration Med Ctr / Regional AIDS Program

๐Ÿ‡บ๐Ÿ‡ธ

Washington, District of Columbia, United States

AIDS Research Alliance - Chicago

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Wishard Hosp / Indiana Univ Hosp

๐Ÿ‡บ๐Ÿ‡ธ

Indianapolis, Indiana, United States

Louisiana Comm AIDS Rsch Prog / Tulane Univ Med

๐Ÿ‡บ๐Ÿ‡ธ

New Orleans, Louisiana, United States

Comprehensive AIDS Alliance of Detroit

๐Ÿ‡บ๐Ÿ‡ธ

Detroit, Michigan, United States

Henry Ford Hosp

๐Ÿ‡บ๐Ÿ‡ธ

Detroit, Michigan, United States

Bronx Lebanon Hosp Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Bronx, New York, United States

North Jersey Community Research Initiative

๐Ÿ‡บ๐Ÿ‡ธ

Newark, New Jersey, United States

Harlem AIDS Treatment Group / Harlem Hosp Ctr

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Portland Veterans Adm Med Ctr / Rsch & Education Grp

๐Ÿ‡บ๐Ÿ‡ธ

Portland, Oregon, United States

Richmond AIDS Consortium

๐Ÿ‡บ๐Ÿ‡ธ

Richmond, Virginia, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath